A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.
USA115th CongressS-2729| Senate
| Updated: 4/23/2018
Richard J. Durbin
Democratic Senator
Illinois
Finance Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Addiction Prevention and Responsible Opioid Practices Act This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)
Latest Companion Bill Action
HR 115-5865Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Health
Alternative treatmentsBusiness ethicsBusiness recordsCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care qualityHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careIndian social and development programsLicensing and registrationsMarketing and advertisingMedical educationMedical ethicsMedicareMilitary medicineMinority healthPrescription drugsSales and excise taxesState and local government operationsUser charges and feesVeterans' medical care
A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.
USA115th CongressS-2729| Senate
| Updated: 4/23/2018
Addiction Prevention and Responsible Opioid Practices Act This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S2343-2346)
Latest Companion Bill Action
HR 115-5865Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Richard J. Durbin
Democratic Senator
Illinois
Finance Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Alternative treatmentsBusiness ethicsBusiness recordsCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care qualityHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careIndian social and development programsLicensing and registrationsMarketing and advertisingMedical educationMedical ethicsMedicareMilitary medicineMinority healthPrescription drugsSales and excise taxesState and local government operationsUser charges and feesVeterans' medical care